Developer docs
API playgroundTry for free, no card

Search company profiles

National Institutes of Health

Full company profile

uuid00004br

Namestring
National Institutes of Health
Legal namestring
National Institutes of Health
Websiteurl
nih.gov
Company typeenum
Public
Founded yearint
1887
Descriptiontext

The National Institutes of Health (NIH) is the principal U.S. federal biomedical research agency, operating as a component of the Department of Health and Human Services and headquartered in Bethesda, Maryland. Established in 1887 and officially designated by Congress in 1930, NIH comprises 27 Institutes and Centers—each focused on a specific disease area or body system (e.g., NCI, NIAID, NHLBI, NHGRI, NIMH, NCATS)—plus the NIH Clinical Center, the nation's largest hospital dedicated to clinical research. The agency combines intramural research at its Bethesda campus with extramural funding distributed through competitive peer review administered by the Center for Scientific Review, which evaluates approximately 100,000 applications annually.

NIH's flagship technical programs include the All of Us Research Program (the world's largest integrated genomic and electronic health record database with 747,000+ participants, 535,000+ whole genome sequences, and 86% representation from historically underrepresented populations), the BRAIN Initiative for neural circuit mapping, the HEAL Initiative for opioid addiction and pain, the Cancer Moonshot, the Accelerating Medicines Partnership (a public-private drug development collaboration with FDA and biopharmaceutical companies), and the RECOVER Initiative for long COVID. Newer programs include ReVAMPP (pandemic preparedness, ~$100 million annually across eight academic institutions) and ORIVA (human-based research technologies). The agency maintains public APIs through PubMed, ClinicalTrials.gov, and NCBI, and operates the Comparative Genomics Resource.

NIH operates on a federal appropriations model, with an FY2026 budget of approximately $47-48 billion set by Congressional action. More than 80% of this funding is distributed as grants and contracts (R01s, SBIR/STTR, cooperative agreements) to academic research institutions, hospitals, individual researchers, and small businesses across all 50 states and globally—reaching more than 10,000 institutions. Primary beneficiary segments include academic research institutions, individual researchers and clinicians (supported via training grants and loan repayment programs up to $50,000 annually), small businesses (via SBIR/STTR non-dilutive funding), and the general public (via MedlinePlus and clinical trial access). The agency reports each federal dollar generates approximately $2.56 in economic activity, with NIH-supported eye disease research alone saving over $28.5 billion in healthcare costs. Jay Bhattacharya serves as the 18th NIH Director following his April 2025 confirmation.

Short descriptiontext

The National Institutes of Health (NIH) is the U.S. federal medical research agency within HHS, comprising 27 Institutes and Centers that fund and conduct biomedical research via approximately $48 billion in annual appropriations, serving academic researchers, healthcare institutions, small businesses, and the public across all 50 states and globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersBethesda, United States
HQ citystring
Bethesda
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical research funding, medical research grants, clinical research programs, public health initiatives, translational science programs
Industry3 codes
1Health Research Funding Agencies (Public/Quasi-Public)
CodeHLAJALABPrimaryYes
2Global Health Research, Evidence & Technical Assistance Organizations
CodeHLAJAKANPrimaryNo
3Research Grants, Fellowships & Stipends (International)
CodeEDAIAOAJPrimaryNo
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Public Biomedical Research Funding
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Federal Appropriations
TypeSubscription Recurring
Description

NIH receives approximately $47-48 billion annually through Congressional appropriations as part of the U.S. Department of Health and Human Services. The agency invests most of its budget in medical research seeking to enhance life and reduce illness and disability. NIH-funded research leads to breakthroughs and new treatments helping people live longer, healthier lives.

nih.gov
2Grants and Contracts Distribution
TypeProfessional Services
Description

NIH distributes funding through various grant mechanisms including research project grants (R01), SBIR/STTR for small businesses, training grants, cooperative agreements, and contracts. More than 80% of research activities are conducted by scientists working in every state and around the world.

nih.gov
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Others
Pricing details2 tiers
1Research Project Grants (R01)
ModelOtherBilling cadenceAnnual
Notes

Grant funding varies by institute, research type, and project scope. Standard research project grants (R01) typically range from $250,000 to $500,000 per year in direct costs, with some larger awards exceeding $1 million annually.

nih.gov
2NIH Loan Repayment Programs
ModelOtherBilling cadenceAnnual
Notes

NIH Loan Repayment Programs repay up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research.

nih.gov
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

NIH funds biomedical and behavioral research through competitive grants, cooperative agreements, and contracts to universities, medical schools, and research institutions, while also operating its own intramural research program at the NIH Clinical Center. It advances public health through large-scale initiatives such as the All of Us Research Program, BRAIN Initiative, HEAL Initiative, Cancer Moonshot, AMP, RECOVER, RADx, SenNet, and ECHO, and supports the research workforce through SBIR/STTR and Loan Repayment Programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over $28.5 billion saved in healthcare costs through NIH-supported eye disease research alone
+4 more records
Product overview1 text field

The National Institutes of Health (NIH) is the nation's medical research agency, comprising 27 Institutes and Centers, that conducts and funds biomedical research to enhance health, lengthen life, and reduce illness and disability. NIH's product portfolio includes major research programs and initiatives such as the All of Us Research Program (the world's largest integrated genomics database), the HEAL Initiative (opioid addiction research), The BRAIN Initiative (neuroscience), Accelerating Medicines Partnership (AMP), RECOVER Initiative (long COVID research), Cancer Moonshot, and ReVAMPP (pandemic preparedness). NIH also provides public health resources including Clinical Trials information, Wellness Toolkits, health information databases through PubMed/Medline, and training programs including the Lasker Clinical Research Scholars Program. The agency operates the NIH Clinical Center (America's research hospital) and funds research through grants and contracts to institutions worldwide.

Product and service1 record
1All of Us Research Program
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-07-22
Description

Samsung collaborated with NIH, CDC, and MIT to develop Samsung Health Assistant, an AI-powered feature analyzing user health data across five areas (sleep, activity, nutrition, mindfulness, and vitals). NIH collaboration aimed to reduce AI errors during development.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-22
Description

Co-Diagnostics awarded $1.2 million from NIH RADx Tech program to complete development of multiplex test for flu A/B, COVID-19, and RSV on its Co-Dx PCR Home testing platform. NIH RADx initiative launched April 2020 to accelerate COVID-19 testing innovation.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-07
Description

SK pharmteco announced strategic partnership with Axle Informatics and NIH to advance gene therapies for rare diseases. SK pharmteco serves as subcontractor to NIH under Axle Informatics as prime contractor, providing manufacturing expertise for lentiviral vectors for treating rare hereditary blood and metabolic disorders. The collaboration combines SK pharmteco's advanced manufacturing capabilities with NIH principal investigators to accelerate academic research into clinical practice.

4Research Triangle Institute
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-13
Description

Research Triangle Institute in North Carolina coordinates the ReVAMPP (Respiratory Viruses and Monoclonal Antibodies Preparedness Program) research network involving eight academic institutions to develop vaccines and monoclonal antibodies against high-priority pathogens with pandemic potential.

nih.gov
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Historic intramural-extramural partnership to nurture next generation of clinical researchers. Lasker Scholars Program supports exceptional clinical researchers with NIH funding for clinical research for up to 10 years, combining intramural program with potential extramural continuation.

6Multiple Biopharmaceutical Companies
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Accelerating Medicines Partnership (AMP) is public-private partnership between NIH, FDA, multiple biopharmaceutical and life science companies, and non-profit organizations to transform drug development. Partners share goal of increasing new diagnostics and therapies and reducing time/cost of development.

nih.gov
Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

The NSF is the U.S. federal agency that funds fundamental research across all non-medical science and engineering fields, with a similar Congressional appropriations model and competitive peer-reviewed grant process. NSF is NIH's closest U.S. peer because both operate as federal research funding agencies, but NSF's broader mandate (no medical focus) makes it an adjacent incumbent rather than direct competitor.

TypeDirect peer
Description

BARDA is an HHS component that funds advanced development of medical countermeasures against chemical, biological, radiological, and nuclear threats, as well as pandemic influenza and emerging infectious diseases. It is NIH's most direct U.S. peer because both sit within HHS, both fund biomedical R&D, and both support translational programs that bridge basic research to clinical application, although BARDA focuses more on product development than basic science.

TypeBroad incumbent
Description

DARPA is the U.S. Department of Defense agency responsible for high-risk, high-reward research programs that have created breakthroughs in internet, GPS, and AI. It is comparable to NIH because both are federal agencies funding breakthrough research through grants and contracts, though DARPA focuses on defense-relevant technologies rather than biomedical science.

TypeDirect peer
Description

The UKRI Medical Research Council is the UK's primary government agency funding biomedical research, with a peer-reviewed grant model and intramural research units that closely parallel NIH's structure. It is one of NIH's most direct international peers given similar funding scale, mandate, and grant mechanisms, although it operates within UK rather than U.S. research infrastructure.

TypeDirect peer
Description

The ERC is the European Union's funding body for frontier research across all disciplines, including life sciences, with grants awarded through competitive peer review. It is directly comparable to NIH because both fund investigator-driven basic research on a multi-billion-Euro scale, though ERC operates across all EU member states rather than within a single national system.

TypeDirect peer
Description

CIHR is the Canadian federal agency that funds health research through 13 Institutes, mirroring NIH's 27 Institutes and Centers structure. It is directly comparable because both are government health research funders using peer-reviewed grants to support academic research institutions, though CIHR operates at a smaller budget scale within Canada.

TypeBroad incumbent
Description

HHMI is the largest private biomedical research organization in the U.S., supporting ~300 HHMI Investigators at universities and operating its own research campus. It is comparable to NIH because both fund frontier biomedical research and operate their own intramural labs, though HHMI uses private philanthropy and investigator-focused appointments rather than open competitive grants.

TypeBroad incumbent
Description

Wellcome is a UK-based charitable foundation that is one of the world's largest funders of biomedical research, supporting both investigator grants and in-house research programs. It is comparable to NIH because both operate at the top tier of global biomedical research funding and prioritize investigator-driven discovery, though Wellcome uses private endowment income rather than government appropriations.

TypeEmerging player
Description

The Gates Foundation is a private foundation that funds global health research and development at scale, particularly for diseases affecting low-income countries. It is comparable to NIH because both fund biomedical research through grants to universities and product development partners, but Gates Foundation focuses on global health equity and infectious diseases while NIH covers the full spectrum of biomedical science.

10German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)
TypeRegional player
Description

The DFG is Germany's primary research funding organization, supporting basic research across all disciplines through competitive peer-reviewed grants. It is comparable to NIH as a major national research funder, though the DFG funds all academic disciplines (including humanities) rather than specializing in biomedical and health sciences.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
Yes

Docs URL, Description

AI capability17 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries27 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1100 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

National Institutes of Health

Public Biomedical Research Fundingnih.gov

The National Institutes of Health (NIH) is the U.S. federal medical research agency within HHS, comprising 27 Institutes and Centers that fund and conduct biomedical research via approximately $48 billion in annual appropriations, serving academic researchers, healthcare institutions, small businesses, and the public across all 50 states and globally.

What National Institutes of Health does

The National Institutes of Health (NIH) is the principal U.S. federal biomedical research agency, operating as a component of the Department of Health and Human Services and headquartered in Bethesda, Maryland. Established in 1887 and officially designated by Congress in 1930, NIH comprises 27 Institutes and Centers—each focused on a specific disease area or body system (e.g., NCI, NIAID, NHLBI, NHGRI, NIMH, NCATS)—plus the NIH Clinical Center, the nation's largest hospital dedicated to clinical research. The agency combines intramural research at its Bethesda campus with extramural funding distributed through competitive peer review administered by the Center for Scientific Review, which evaluates approximately 100,000 applications annually.

NIH's flagship technical programs include the All of Us Research Program (the world's largest integrated genomic and electronic health record database with 747,000+ participants, 535,000+ whole genome sequences, and 86% representation from historically underrepresented populations), the BRAIN Initiative for neural circuit mapping, the HEAL Initiative for opioid addiction and pain, the Cancer Moonshot, the Accelerating Medicines Partnership (a public-private drug development collaboration with FDA and biopharmaceutical companies), and the RECOVER Initiative for long COVID. Newer programs include ReVAMPP (pandemic preparedness, ~$100 million annually across eight academic institutions) and ORIVA (human-based research technologies). The agency maintains public APIs through PubMed, ClinicalTrials.gov, and NCBI, and operates the Comparative Genomics Resource.

NIH operates on a federal appropriations model, with an FY2026 budget of approximately $47-48 billion set by Congressional action. More than 80% of this funding is distributed as grants and contracts (R01s, SBIR/STTR, cooperative agreements) to academic research institutions, hospitals, individual researchers, and small businesses across all 50 states and globally—reaching more than 10,000 institutions. Primary beneficiary segments include academic research institutions, individual researchers and clinicians (supported via training grants and loan repayment programs up to $50,000 annually), small businesses (via SBIR/STTR non-dilutive funding), and the general public (via MedlinePlus and clinical trial access). The agency reports each federal dollar generates approximately $2.56 in economic activity, with NIH-supported eye disease research alone saving over $28.5 billion in healthcare costs. Jay Bhattacharya serves as the 18th NIH Director following his April 2025 confirmation.

National Institutes of Health firmographics

Firmographics
Name
National Institutes of Health
Legal name
National Institutes of Health
Website
https://nih.gov
Company type
Public
Founded year
1887
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
The National Institutes of Health (NIH) is the U.S. federal medical research agency within HHS, comprising 27 Institutes and Centers that fund and conduct biomedical research via approximately $48 billion in annual appropriations, serving academic researchers, healthcare institutions, small businesses, and the public across all 50 states and globally.
Ownership category
akta.pro rank

National Institutes of Health industry classification

Industry
Product category
Public Biomedical Research Funding
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Health Research Funding Agencies (Public/Quasi-Public) (HLAJALAB)
akta.pro secondary industries
Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN), Research Grants, Fellowships & Stipends (International) (EDAIAOAJ)

Keywords

  • Biomedical research funding
  • Medical research grants
  • Clinical research programs
  • Public health initiatives
  • Translational science programs

Where National Institutes of Health is headquartered

Location

Headquarters

HQ city
Bethesda
HQ country
United States
HQ region
North America

Offices6 records

Markets served

National Institutes of Health business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

  1. Federal Appropriations: NIH receives approximately $47-48 billion annually through Congressional appropriations as part of the U.S. Department of Health and Human Services. The agency invests most of its budget in medical research seeking to enhance life and reduce illness and disability. NIH-funded research leads to breakthroughs and new treatments helping people live longer, healthier lives.
  2. Grants and Contracts Distribution: NIH distributes funding through various grant mechanisms including research project grants (R01), SBIR/STTR for small businesses, training grants, cooperative agreements, and contracts. More than 80% of research activities are conducted by scientists working in every state and around the world.

Pricing tiers

ModelBillingPrice
OtherAnnualResearch Project Grants (R01)
OtherAnnualNIH Loan Repayment Programs

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

National Institutes of Health product offering

Product offering

Core offering

NIH funds biomedical and behavioral research through competitive grants, cooperative agreements, and contracts to universities, medical schools, and research institutions, while also operating its own intramural research program at the NIH Clinical Center. It advances public health through large-scale initiatives such as the All of Us Research Program, BRAIN Initiative, HEAL Initiative, Cancer Moonshot, AMP, RECOVER, RADx, SenNet, and ECHO, and supports the research workforce through SBIR/STTR and Loan Repayment Programs.

Product overview

The National Institutes of Health (NIH) is the nation's medical research agency, comprising 27 Institutes and Centers, that conducts and funds biomedical research to enhance health, lengthen life, and reduce illness and disability. NIH's product portfolio includes major research programs and initiatives such as the All of Us Research Program (the world's largest integrated genomics database), the HEAL Initiative (opioid addiction research), The BRAIN Initiative (neuroscience), Accelerating Medicines Partnership (AMP), RECOVER Initiative (long COVID research), Cancer Moonshot, and ReVAMPP (pandemic preparedness). NIH also provides public health resources including Clinical Trials information, Wellness Toolkits, health information databases through PubMed/Medline, and training programs including the Lasker Clinical Research Scholars Program. The agency operates the NIH Clinical Center (America's research hospital) and funds research through grants and contracts to institutions worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

  • All of Us Research Program

Quantifiable outcome

  • Over $28.5 billion saved in healthcare costs through NIH-supported eye disease research alone
  • +4 more outcomes

Companies that use National Institutes of Health

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles4 records

National Institutes of Health technology and API

Technology

Technology focussed No

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability17 records

Feature3 records

National Institutes of Health partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • SamsungminorStrategic or Co-development Partner · 22 July 2026Samsung collaborated with NIH, CDC, and MIT to develop Samsung Health Assistant, an AI-powered feature analyzing user health data across five areas (sleep, activity, nutrition, mindfulness, and vitals). NIH collaboration aimed to reduce AI errors during development.
  • Co-Diagnostics, Inc.minorStrategic or Co-development Partner · 22 May 2026Co-Diagnostics awarded $1.2 million from NIH RADx Tech program to complete development of multiplex test for flu A/B, COVID-19, and RSV on its Co-Dx PCR Home testing platform. NIH RADx initiative launched April 2020 to accelerate COVID-19 testing innovation.
  • SK pharmtecocoreStrategic or Co-development Partner · 7 May 2026SK pharmteco announced strategic partnership with Axle Informatics and NIH to advance gene therapies for rare diseases. SK pharmteco serves as subcontractor to NIH under Axle Informatics as prime contractor, providing manufacturing expertise for lentiviral vectors for treating rare hereditary blood and metabolic disorders. The collaboration combines SK pharmteco's advanced manufacturing capabilities with NIH principal investigators to accelerate academic research into clinical practice.
  • Research Triangle InstitutecoreStrategic or Co-development Partner · 13 September 2024Research Triangle Institute in North Carolina coordinates the ReVAMPP (Respiratory Viruses and Monoclonal Antibodies Preparedness Program) research network involving eight academic institutions to develop vaccines and monoclonal antibodies against high-priority pathogens with pandemic potential.
  • Lasker FoundationcoreStrategic or Co-development PartnerHistoric intramural-extramural partnership to nurture next generation of clinical researchers. Lasker Scholars Program supports exceptional clinical researchers with NIH funding for clinical research for up to 10 years, combining intramural program with potential extramural continuation.
  • Multiple Biopharmaceutical CompaniescoreStrategic or Co-development PartnerAccelerating Medicines Partnership (AMP) is public-private partnership between NIH, FDA, multiple biopharmaceutical and life science companies, and non-profit organizations to transform drug development. Partners share goal of increasing new diagnostics and therapies and reducing time/cost of development.

Scale indicators10 records

Recent moves12 records

Expansion highlights6 records

National Institutes of Health competitors and assessment

Company assessment

Broad incumbents

  • National Science Foundation: The NSF is the U.S. federal agency that funds fundamental research across all non-medical science and engineering fields, with a similar Congressional appropriations model and competitive peer-reviewed grant process. NSF is NIH's closest U.S. peer because both operate as federal research funding agencies, but NSF's broader mandate (no medical focus) makes it an adjacent incumbent rather than direct competitor.
  • Defense Advanced Research Projects Agency (DARPA): DARPA is the U.S. Department of Defense agency responsible for high-risk, high-reward research programs that have created breakthroughs in internet, GPS, and AI. It is comparable to NIH because both are federal agencies funding breakthrough research through grants and contracts, though DARPA focuses on defense-relevant technologies rather than biomedical science.
  • Howard Hughes Medical Institute (HHMI): HHMI is the largest private biomedical research organization in the U.S., supporting ~300 HHMI Investigators at universities and operating its own research campus. It is comparable to NIH because both fund frontier biomedical research and operate their own intramural labs, though HHMI uses private philanthropy and investigator-focused appointments rather than open competitive grants.
  • Wellcome Trust: Wellcome is a UK-based charitable foundation that is one of the world's largest funders of biomedical research, supporting both investigator grants and in-house research programs. It is comparable to NIH because both operate at the top tier of global biomedical research funding and prioritize investigator-driven discovery, though Wellcome uses private endowment income rather than government appropriations.

Direct peers

  • Biomedical Advanced Research Development Authority (BARDA): BARDA is an HHS component that funds advanced development of medical countermeasures against chemical, biological, radiological, and nuclear threats, as well as pandemic influenza and emerging infectious diseases. It is NIH's most direct U.S. peer because both sit within HHS, both fund biomedical R&D, and both support translational programs that bridge basic research to clinical application, although BARDA focuses more on product development than basic science.
  • Medical Research Council (UKRI-MRC): The UKRI Medical Research Council is the UK's primary government agency funding biomedical research, with a peer-reviewed grant model and intramural research units that closely parallel NIH's structure. It is one of NIH's most direct international peers given similar funding scale, mandate, and grant mechanisms, although it operates within UK rather than U.S. research infrastructure.
  • European Research Council (ERC): The ERC is the European Union's funding body for frontier research across all disciplines, including life sciences, with grants awarded through competitive peer review. It is directly comparable to NIH because both fund investigator-driven basic research on a multi-billion-Euro scale, though ERC operates across all EU member states rather than within a single national system.
  • Canadian Institutes of Health Research (CIHR): CIHR is the Canadian federal agency that funds health research through 13 Institutes, mirroring NIH's 27 Institutes and Centers structure. It is directly comparable because both are government health research funders using peer-reviewed grants to support academic research institutions, though CIHR operates at a smaller budget scale within Canada.

Emerging players

  • Bill & Melinda Gates Foundation: The Gates Foundation is a private foundation that funds global health research and development at scale, particularly for diseases affecting low-income countries. It is comparable to NIH because both fund biomedical research through grants to universities and product development partners, but Gates Foundation focuses on global health equity and infectious diseases while NIH covers the full spectrum of biomedical science.

Regional players

  • German Research Foundation (Deutsche Forschungsgemeinschaft, DFG): The DFG is Germany's primary research funding organization, supporting basic research across all disciplines through competitive peer-reviewed grants. It is comparable to NIH as a major national research funder, though the DFG funds all academic disciplines (including humanities) rather than specializing in biomedical and health sciences.

Market position

Strengths3 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

National Institutes of Health social profiles

Digital presence

National Institutes of Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

National Institutes of Health leadership team

Management profile

Number of profiles

Profiles6 records

National Institutes of Health subsidiaries and ownership

Company hierarchy

Subsidiaries27 records

National Institutes of Health funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

National Institutes of Health M&A and investment

M&A and investment

M&A

Investments1100 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institutes of Health

What does National Institutes of Health do?

NIH funds biomedical and behavioral research through competitive grants, cooperative agreements, and contracts to universities, medical schools, and research institutions, while also operating its own intramural research program at the NIH Clinical Center. It advances public health through large-scale initiatives such as the All of Us Research Program, BRAIN Initiative, HEAL Initiative, Cancer Moonshot, AMP, RECOVER, RADx, SenNet, and ECHO, and supports the research workforce through SBIR/STTR and Loan Repayment Programs.

Is National Institutes of Health a public or private company?

National Institutes of Health is a public company. It is classified as state government owned and is currently operating.

When was National Institutes of Health founded?

National Institutes of Health was founded in 1887. It employs 5,001 to 10,000 people.

Where is National Institutes of Health based?

National Institutes of Health is headquartered in Bethesda, United States, in the North America region.

How does National Institutes of Health make money?

Two revenue lines are on record. Federal Appropriations are the primary driver. The others are grants and Contracts Distribution.

Who are National Institutes of Health's main competitors?

Broad incumbents on record are National Science Foundation, Defense Advanced Research Projects Agency (DARPA), Howard Hughes Medical Institute (HHMI) and Wellcome Trust. Direct peers are Biomedical Advanced Research Development Authority (BARDA), Medical Research Council (UKRI-MRC), European Research Council (ERC) and Canadian Institutes of Health Research (CIHR). Bill & Melinda Gates Foundation is listed as an emerging player. German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) is listed as a regional player.

Does National Institutes of Health have an API?

Yes. NIH provides API access through multiple resources: PubMed offers a public API for scientific literature searching and retrieval; ClinicalTrials.gov provides an API for accessing clinical trial data; and various NIH data resources offer programmatic access. The National Library of Medicine (NLM) APIs enable access to biomedical literature, genomic data, and health information databases. Developer documentation is at www.ncbi.nlm.nih.gov/home/develop/api.

What industry is National Institutes of Health in?

National Institutes of Health's product category is Public Biomedical Research Funding. Its primary akta.pro industry code is HLAJALAB, Health Research Funding Agencies (Public/Quasi-Public), with a secondary code of HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BenzingaDLH Clinches $19.1 Million NIH Cybersecurity Deal - DLH Holdings (NASDAQ:DLHC)DLH Holdings secured a new cybersecurity task order worth up to $19.1 million from the National Institutes of Health. The three-year contract covers risk management, cybersecurity operations, and support for zero-trust security and AI. DLH will work with other providers to deliver the services.EIN PresswireInformAI, Inc. Receives $1M in NIH Grant Funding for Innovative Use of AI in Organ TransplantationInformAI, Inc. received $1 million in NIH grant funding for the second year of its Fast-Track grant, supporting TransplantAI, an AI tool that optimizes donor-organ matching for heart, lung, kidney, and liver transplants. The tool has shown superior predictive accuracy for transplant outcomes compared to existing clinical decision support tools. The funding aims to address organ scarcity and improve waitlist mortality assessment.American City Business JournalsXLerateHealth gets $2.5M NIH grant for life science platformXLerateHealth received a $2.5 million NIH grant to expand its software architecture, curriculum, and digital tools. The organization's pilot program supported startups across 10 universities.Business Wire BlogXLerateHealth Awarded $2.5M NIH Phase IIB Grant to Accelerate National Expansion of Its Enterprise Commercialization EngineXLerateHealth received a $2.5 million Phase IIB SBIR grant from the NIH to expand its enterprise commercialization platform. The platform supports universities, biotech hubs, and health systems, building on a pilot that raised $20.46 million in follow-on capital. The company plans to scale nationally.ReutersScientists challenge US NIH grant screening as unconstitutionalScientists filed a class-action lawsuit against the U.S. National Institutes of Health, alleging unconstitutional grant screening that suppresses viewpoints on diversity, gender identity, and climate change. The suit names NIH Director Jay Bhattacharya, Health Secretary Robert F. Kennedy Jr., and DOGE as defendants, citing a list of 235 keywords used to flag grants. It seeks to vacate policies and restore terminated grants.BioSpaceMAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical TrialMAIA Biotechnology dosed the first U.S. patient in its Phase 2 THIO-101 trial for ateganosine in third-line non-small cell lung cancer. The expansion is funded by a $2.3 million NIH grant, and MAIA activated three U.S. sites. The company expects data may support a potential FDA accelerated approval pathway.BioSpaceFeinstein Institutes Awarded $8.9M for Care Planning Program in Older Adults and Those With DementiaNorthwell Health's Feinstein Institutes received an $8.9 million NIH grant to run the AEGIS clinical trial, which will use video education and trained educators to help older adults and those with dementia make informed care decisions. The trial is part of a larger $40 million NIA grant and aims to improve quality of life and reduce healthcare burdens.SciencedailyScientists find Ozempic may slow aging itselfA National Institutes of Health funded study found that semaglutide, the active ingredient in Ozempic and Wegovy, extended lifespan in older, healthy mice. The drug also improved memory, muscle function, and reduced several biological signs of aging.Mirage News$26M Federal Grant Boosts RI Clinical ResearchThe National Institutes of Health awarded a $26 million grant to Advance RI-CTR, a Brown University-based clinical and translational research program in Rhode Island. The funding will support the program's expansion into a third five-year phase, continuing its work to connect research, healthcare, communities, and patients across the state.EIN PresswireORAL BIOLIFE AWARDED NIH GRANT TO ADVANCE PIEZOELECTRIC REGENERATIVE PLATFORM FOR PERI-IMPLANTITISOral Biolife received an NIH grant to evaluate its piezoelectric regenerative platform for peri-implantitis, a condition causing bone loss around dental implants. The study, led by Temple University's Ronaldo Santana, aims to assess the technology as a non-surgical treatment. The company plans to explore additional dental and craniofacial applications.